NDA Help Center

Login Dialog

Frequently Asked Questions

Glossary

NDA Help Center

Filter Cart

The Filter Cart provides a powerful way to query and access data for which you may be interested.  

A few points related to the filter cart are important to understand with the NDA Query/Filter implementation: 

First, the filter cart is populated asyncronously.  So, when you run a query, it may take a moment to populate but this will happen in the background so you can define other queries during this time.  

When you are adding your first filter, all data associated with your query will be added to the filter cart (whether it be a collection, a concept, a study, a data structure/elment or subjects). Not all data structures or collections will necessarily be displayed.  For example, if you select the NDA imaging structure image03, and further restrict that query to scan_type fMRI, only fMRI images will appear and only the image03 structure will be shown.  To see other data structures, select "Find All Subject Data" which will query all data for those subjects. When a secord or third filter is applied, an AND condition is used.  A subject must exist in all filters.  If the subject does not appear in any one filter, that subjects data will not be included in your filter cart. If that happens, clear your filter cart, and start over.  

It is best to package more data than you need and access those data using other tools, independent of the NDA (e.g. miNDAR snapshot), to limit the data selected.  If you have any questions on data access, are interested in using avaialble web services, or need help accessing data, please contact us for assistance.  

Frequently Asked Questions

Glossary

Loading...

Login
Reset Password

NDA provides a single access to de-identified autism research data. For permission to download data, you will need an NDA account with approved access to NDA or a connected repository (AGRE, IAN, or the ATP). For NDA access, you need to be a research investigator sponsored by an NIH recognized institution with federal wide assurance. See Request Access for more information.

Warning Notice

This is a U.S. Government computer system, which may be accessed and used only for authorized Government business by authorized personnel. Unauthorized access or use of this computer system may subject violators to criminal, civil, and/or administrative action. All information on this computer system may be intercepted, recorded, read, copied, and disclosed by and to authorized personnel for official purposes, including criminal investigations. Such information includes sensitive data encrypted to comply with confidentiality and privacy requirements. Access or use of this computer system by any person, whether authorized or unauthorized, constitutes consent to these terms. There is no right of privacy in this system.

Update Password

You have logged in with a temporary password. Please update your password. Passwords must contain 8 or more characters and must contain at least 3 of the following types of characters:

  • Uppercase
  • Lowercase
  • Numbers
  • Special Characters limited to: %,_,!,@,#,$,-,%,&,+,=,),(,*,^,:,;

Subscribe to our mailing list

Mailing List(s)
Email Format

You are now leaving the NIMH Data Archive (NDA) web site to go to:

Click on the address above if the page does not change within 10 seconds.

Disclaimer

NDA is not responsible for the content of this external site and does not monitor other web sites for accuracy.

Accept Terms
Filter Cart
No filters selected
Description
Value Range
Notes
Data Structures with shared data
No filters have been selected
Switch User

Comprehensive Post-Session Questionnaire

0 Shared Subjects

N/A
Clinical Assessments
Questionnaire
01/02/2018
cpsq01
01/03/2018
View Change History
01
Query Element Name Data Type Size Required Description Value Range Notes Aliases
subjectkey GUID Required The NDAR Global Unique Identifier (GUID) for research subject NDAR*
src_subject_id String 20 Required Subject ID how it's defined in lab/project
interview_date Date Required Date on which the interview/genetic test/sampling/imaging/biospecimen was completed. MM/DD/YYYY Required field
interview_age Integer Required Age in months at the time of the interview/test/sampling/imaging. 0 :: 1260 Age is rounded to chronological month. If the research participant is 15-days-old at time of interview, the appropriate value would be 0 months. If the participant is 16-days-old, the value would be 1 month.
sex String 20 Required Sex of the subject M;F M = Male; F = Female gender
cpsq01 Integer Recommended To what extent did you experience tingling DURING tDCS/tACS 0::10 Higher number indicates greater symptom severity
cpsq02 Integer Recommended To what extent did you experience an itching sensation DURING tDCS/tACS 0::10 Higher number indicates greater symptom severity
cpsq03 Integer Recommended To what extent did you experience a burning sensation DURING tDCS/tACS 0::10 Higher number indicates greater symptom severity
cpsq04 Integer Recommended To what extent did you experience pain DURING tDCS/tACS 0::10 Higher number indicates greater symptom severity
cpsq05 Integer Recommended To what extent did you experience fatigue DURING tDCS/tACS 0::10 Higher number indicates greater symptom severity
cpsq06 Integer Recommended To what extent did you experience nervousness DURING tDCS/tACS 0::10 Higher number indicates greater symptom severity
cpsq07 Integer Recommended To what extent did you experience headache DURING tDCS/tACS 0::10 Higher number indicates greater symptom severity
cpsq08 Integer Recommended To what extent did you experience difficulty concentrating DURING tDCS/tACS 0::10 Higher number indicates greater symptom severity
cpsq09 Integer Recommended To what extent did you experience a mood change DURING tDCS/tACS 0::10 Higher number indicates greater symptom severity
cpsq10 Integer Recommended To what extent did you experiencechange in your vision/visual perception DURING tDCS/tACS 0::10 Higher number indicates greater symptom severity
cpsq11 Integer Recommended To what extent did you experience visual sensation (seeing lights for example) associated with the start or end of stimulation/the stimulation DURING tDCS/tACS 0::10 Higher number indicates greater symptom severity
cpsq12 Integer Recommended Other effects DURING tDAS/tACS 0::10 Higher number indicates greater symptom severity
cpsq13 String 100 Recommended Describe other effects DURING tDAS/tACS
cpsq14 Integer Recommended To what extent did you experience tingling AFTER tDCS/tACS 0::10 Higher number indicates greater symptom severity
cpsq15 Integer Recommended To what extent did you experience an itching sensation AFTER tDCS/tACS 0::10 Higher number indicates greater symptom severity
cpsq16 Integer Recommended To what extent did you experience a burning sensation AFTER tDCS/tACS 0::10 Higher number indicates greater symptom severity
cpsq17 Integer Recommended To what extent did you experience pain AFTER tDCS/tACS 0::10 Higher number indicates greater symptom severity
cpsq18 Integer Recommended To what extent did you experience fatigue AFTER tDCS/tACS 0::10 Higher number indicates greater symptom severity
cpsq19 Integer Recommended To what extent did you experience nervousness AFTER tDCS/tACS 0::10 Higher number indicates greater symptom severity
cpsq20 Integer Recommended To what extent did you experience headache AFTER tDCS/tACS 0::10 Higher number indicates greater symptom severity
cpsq21 Integer Recommended To what extent did you experience difficulty concentrating AFTER tDCS/tACS 0::10 Higher number indicates greater symptom severity
cpsq22 Integer Recommended To what extent did you experience a mood change AFTER tDCS/tACS 0::10 Higher number indicates greater symptom severity
cpsq23 Integer Recommended To what extent did you experiencechange in your vision/visual perception AFTER tDCS/tACS 0::10 Higher number indicates greater symptom severity
cpsq24 Integer Recommended Other effects AFTER tDAS/tACS 0::10 Higher number indicates greater symptom severity
cpsq25 String 100 Recommended Describe other effects AFTER tDAS/tACS
cpsq26 Integer Recommended To what extent did you experience tingling in the WEEK PRIOR to tDCS/tACS 0::10 Higher number indicates greater symptom severity
cpsq27 Integer Recommended To what extent did you experience an itching sensation in the WEEK PRIOR to tDCS/tACS 0::10 Higher number indicates greater symptom severity
cpsq28 Integer Recommended To what extent did you experience a burning sensation in the WEEK PRIOR to tDCS/tACS 0::10 Higher number indicates greater symptom severity
cpsq29 Integer Recommended To what extent did you experience pain in the WEEK PRIOR to tDCS/tACS 0::10 Higher number indicates greater symptom severity
cpsq30 Integer Recommended To what extent did you experience fatigue in the WEEK PRIOR to tDCS/tACS 0::10 Higher number indicates greater symptom severity
cpsq31 Integer Recommended To what extent did you experience nervousness in the WEEK PRIOR to tDCS/tACS 0::10 Higher number indicates greater symptom severity
cpsq32 Integer Recommended To what extent did you experience headache in the WEEK PRIOR to tDCS/tACS 0::10 Higher number indicates greater symptom severity
cpsq33 Integer Recommended To what extent did you experience difficulty concentrating in the WEEK PRIOR to tDCS/tACS 0::10 Higher number indicates greater symptom severity
cpsq34 Integer Recommended To what extent did you experience a mood change in the WEEK PRIOR to tDCS/tACS 0::10 Higher number indicates greater symptom severity
cpsq35 Integer Recommended To what extent did you experiencechange in your vision/visual perception in the WEEK PRIOR to tDCS/tACS 0::10 Higher number indicates greater symptom severity
cpsq36 Integer Recommended To what extent did you experience visual sensation (seeing lights for example) associated with the start or end of stimulation/the stimulation in the WEEK PRIOR to tDCS/Tacs 0::10 Higher number indicates greater symptom severity
cpsq37 Integer Recommended Other effects in the WEEK PRIOR to tDAS/tACS 0::10 Higher number indicates greater symptom severity
cpsq38 String 100 Recommended Describe other effects in the WEEK PRIOR to tDAS/tACS
Data Structure

This page displays the data structure defined for the measure identified in the title and structure short name. The table below displays a list of data elements in this structure (also called variables) and the following information:

  • Element Name: This is the standard element name
  • Data Type: Which type of data this element is, e.g. String, Float, File location.
  • Size: If applicable, the character limit of this element
  • Required: This column displays whether the element is Required for valid submissions, Recommended for valid submissions, Conditional on other elements, or Optional
  • Description: A basic description
  • Value Range: Which values can appear validly in this element (case sensitive for strings)
  • Notes: Expanded description or notes on coding of values
  • Aliases: A list of currently supported Aliases (alternate element names)
  • For valid elements with shared data, on the far left is a Filter button you can use to view a summary of shared data for that element and apply a query filter to your Cart based on selected value ranges

At the top of this page you can also:

  • Use the search bar to filter the elements displayed. This will not filter on the Size of Required columns
  • Download a copy of this definition in CSV format
  • Download a blank CSV submission template prepopulated with the correct structure header rows ready to fill with subject records and upload

Please email the The NDA Help Desk with any questions.